Gene therapy targeting Tie2 receptor tyrosine kinase evaluated as antiangiogenic strategy Oct. 13, 1998
Onconase and proteasome inhibitors have synergistic antitumor activity, even in resistant tumors Oct. 8, 1998
RSS